Literature DB >> 3250184

Bacteriological findings and clinical symptoms in relation to clinical outcome in puerperal mastitis.

I Matheson1, I Aursnes, M Horgen, O Aabø, K Melby.   

Abstract

Clinical symptoms, bacterial content in breast milk and treatment were recorded in 43 women in Oslo with puerperal mastitis. Patients with a favorable (n = 35) and unfavorable outcome (n = 8) (defined as abscess formation and/or symptom relief after more than 7 days) were compared. The group with unfavorable outcome was characterized by increased delay between symptoms and time for consultation, higher score of clinical symptoms and higher frequency of Staphylococcus aureus. A higher frequency of S. aureus was found in the affected breasts than in the unaffected breasts. There was no difference concerning the frequency of coagulase-negative staphylococci and overall bacterial counts, either between milk from affected and non-affected breasts, or between milk from non-affected breasts and milk from healthy donors. The present investigation indicates that penicillin treatment is questionable when considering that untreated cases healed almost as quickly as treated ones, and that 70% of the S. aureus strains were resistant to phenoxymethylpenicillin. It is concluded that present bacterial examinations in breast milk are of limited help in deciding who needs antibiotic treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3250184     DOI: 10.3109/00016349809004296

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  11 in total

Review 1.  Methicillin resistant S. aureus in human and bovine mastitis.

Authors:  Mark A Holmes; Ruth N Zadoks
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-08       Impact factor: 2.673

2.  Mastitis and immunological factors in breast milk of lactating women in Malawi.

Authors:  R D Semba; N Kumwenda; T E Taha; D R Hoover; Y Lan; W Eisinger; L Mtimavalye; R Broadhead; P G Miotti; L Van Der Hoeven; J D Chiphangwi
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

3.  Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides.

Authors:  David C Dallas; Andres Guerrero; Nora Khaldi; Patricia A Castillo; William F Martin; Jennifer T Smilowitz; Charles L Bevins; Daniela Barile; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2013-04-24       Impact factor: 4.466

4.  ABM clinical protocol #4: Mastitis, revised March 2014.

Authors:  Lisa H Amir
Journal:  Breastfeed Med       Date:  2014-06       Impact factor: 1.817

5.  Drug utilization in breast-feeding women. A survey in Oslo.

Authors:  I Matheson; K Kristensen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  The role of co-infections in mother-to-child transmission of HIV.

Authors:  Caroline C King; Sascha R Ellington; Athena P Kourtis
Journal:  Curr HIV Res       Date:  2013-01       Impact factor: 1.581

7.  A case-control study of mastitis: nasal carriage of Staphylococcus aureus.

Authors:  Lisa H Amir; Suzanne M Garland; Judith Lumley
Journal:  BMC Fam Pract       Date:  2006-10-11       Impact factor: 2.497

8.  Mammary candidiasis: A medical condition without scientific evidence?

Authors:  Esther Jiménez; Rebeca Arroyo; Nivia Cárdenas; María Marín; Pilar Serrano; Leonides Fernández; Juan M Rodríguez
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

9.  Antepartum mastitis: a case report.

Authors:  M Smith-Levitin; D W Skupski
Journal:  Infect Dis Obstet Gynecol       Date:  1995

10.  The role of bacteria in lactational mastitis and some considerations of the use of antibiotic treatment.

Authors:  Linda J Kvist; Bodil Wilde Larsson; Marie Louise Hall-Lord; Anita Steen; Claes Schalén
Journal:  Int Breastfeed J       Date:  2008-04-07       Impact factor: 3.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.